# XenoTherapeutics Corp — Form D/A

XenoTherapeutics Corp of Enfield, NH, a company, filed a Form D amendment with the SEC on 2019-06-25. The offering totals $4.0M, of which $700K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-06-25
- Form: D/A
- Accession: 0001774010-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $700K
- Remaining: $3.3M
- Investors: 5
- Date of first sale: 2019-05-22
- Security types: equity, debt
- Revenue range: No Revenues
- SEC file number: 021-340069

## Issuer

- Name: XenoTherapeutics Corp
- CIK: 0001774010
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3 Sunset Walk, Enfield, NH, 03748
- Phone: 2072630226

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Krysta Moulton | Director | Arlington, VA |
| Krysta Moulton | Executive Officer | Arlington, VA |
| Paul Holzer | Director | Enfield, NH |
| Paul Holzer | Executive Officer | Enfield, NH |
| Jon Adkins | Director | Londonderry, NH |
| Jon Adkins | Executive Officer | Londonderry, NH |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-04-06](https://search.stillhousedata.com/formd/0001774010-21-000002) | D | $8.0M | $1.3M |
| [2019-05-21](https://search.stillhousedata.com/formd/0001774010-19-000001) | D | $4.0M | — |

## More

- [CIK 1774010 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1774010&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001774010-19-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.